Form 4: Marvell Technology COO Chris Koopmans Sells 6,000 Shares Under 10b5-1 Plan
SEC Form 4 Filing
Marvell Technology's Chief Operating Officer, Chris Koopmans, sold 6,000 shares of common stock at $65 per share on May 12, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Chris Koopmans, the Chief Operating Officer of Marvell Technology, sold 6,000 shares of common stock on May 12, 2025.
- The sale was executed at a price of $65 per share.
- The transaction was conducted under a pre-existing 10b5-1 trading plan adopted on June 17, 2024.
- Following the transaction, Koopmans directly owns no shares but indirectly owns 98,065 shares through a family trust.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an insider stock sale under a pre-arranged plan, so it has a neutral sentiment.
Industry Context
Insider sales are a common occurrence, and the use of 10b5-1 plans allows corporate insiders to sell shares over a predetermined period, avoiding concerns about trading on non-public information. The market typically views these sales in the context of the overall trading volume and the company's performance.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date the 10b5-1 trading plan was adopted |
| 05/12/2025 | Date of the stock sale transaction |
| 05/13/2025 | Date of the Form 4 filing |
Keywords
Marvell Technology, Chris Koopmans, stock sale, Form 4, 10b5-1 plan, insider trading, MRVL, Chief Operating Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.